Document is current

Any future updates will be listed below

Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

Crossref DOI link: https://doi.org/10.1186/s40644-016-0063-7

Published Online: 2016-03-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark